DiluTab

DiluTab is line of ready-to-use excipient systems engineered to make tablet compounding simpler, faster, and more reproducible in pharmacy-scale settings.

The importance of excipients in tablets compounding

Tablets are the most widely used dosage form globally due to their convenience, stability, accuracy, and versatility. Their successful development relies on the careful selection and optimization of excipients, which influence not only the manufacturability of the tablets but also their bioavailability, release kinetics, mechanical resistance, disintegration, organoleptic characteristics, and patient adherence. In the context of personalized medicine and pharmaceutical compounding, the formulation process must be flexible to accommodate a wide range of APIs with differing physicochemical properties. In response to the demand for reliable, versatile, and scientifically engineered tablet excipients, Fagron developed the DiluTab line, tailored for the specific needs of direct compression tablet compounding.

DiluTab Brochure

DiluTab – The right excipient for your tablets

DiluTab was carefully developed to be easy to compound with. It effectively addresses APIs’ physicochemical properties, modulates their release and bioavailability, and promotes adequate dissolution of both soluble and poorly soluble APIs. Each DiluTab product was developed with scientific rigor and tested extensively to meet the needs of pharmacists in routine compounding—whether for immediate-release, orodispersible, or pediatric-friendly tablets.

  • DiluTab DC: designed for direct compression immediate-release tablets, with great flow properties and high compressibility.
  • DiluTab OD SL: especially developed for orodispersible and sublingual tablets, supporting adequate disintegration, enhancing treatment compliance in special patient groups.
  • DiluTab Mini: designed for compounding mini-tablets (<3mm) with high precision, ideal for pediatric patients and dose titration treatment approaches.

Complementary Documents

Key Advantages

Ready-to-use excipient system
Modulates API’s solubility and permeability
Validated and reliable